Equity
Total Liabilities & Equity
Gilead Sciences Total Liabilities & Equity increased by 0.8% to $59.02B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.0%, from $59.00B to $59.02B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows a downward trend with a -2.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase typically reflects overall balance sheet growth or expansion of the company's asset base, while a decrease may indicate divestitures or debt repayment.
Detailed definition
This represents the sum of all claims against a company's assets, combining obligations to external creditors and the re...
Peer comparison
This is a standard accounting identity used across all industries to verify that assets equal the sum of liabilities and equity.
Metric ID:
total_liabilities_and_equityHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $67.98B | $67.10B | $67.95B | $63.08B | $62.87B | $62.56B | $63.17B | $61.88B | $62.34B | $62.37B | $62.13B | $56.29B | $53.58B | $54.53B | $59.00B | $56.43B | $55.72B | $58.53B | $59.02B |
| QoQ Change | — | -1.3% | +1.3% | -7.2% | -0.3% | -0.5% | +1.0% | -2.0% | +0.7% | +0.1% | -0.4% | -9.4% | -4.8% | +1.8% | +8.2% | -4.3% | -1.3% | +5.0% | +0.8% |
| YoY Change | — | — | — | — | -7.5% | -6.8% | -7.0% | -1.9% | -0.8% | -0.3% | -1.7% | -9.0% | -14.0% | -12.6% | -5.0% | +0.3% | +4.0% | +7.4% | +0.0% |
Range$53.58B – $67.98B
CAGR-3.1%
Avg YoY Growth-3.7%
Median YoY Growth-1.9%
Current Streak2 quarters growth
Total Liabilities & Equity at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's total liabilities & equity?
- Gilead Sciences (GILD) reported total liabilities & equity of $59.02B in Q4 2025.
- How has Gilead Sciences's total liabilities & equity changed year-over-year?
- Gilead Sciences's total liabilities & equity increased by 0.0% year-over-year, from $59.00B to $59.02B.
- What is the long-term trend for Gilead Sciences's total liabilities & equity?
- Over 5 years (2020 to 2025), Gilead Sciences's total liabilities & equity has grown at a -2.9% compound annual growth rate (CAGR), from $68.41B to $59.02B.
- What does total liabilities & equity mean?
- The total amount of money a company owes to others plus the value owned by its shareholders.